Search

everythinglearnresearchcommunity

for

Search:↓

An infant with seizures and hair loss was diagnosed with biotinidase deficiency and treated successfully with biotin.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Bovines can have rare inherited skin diseases with specific symptoms like hair loss, fragile skin, and abnormal porphyrin buildup.

Doctors need more training in skin cancer screening, a new treatment is effective for a skin condition, better diagnosis methods for skin cancer are available, hair loss in women may be linked to hormones and cholesterol, certain skin care products might cause hair loss, babies' skin gets weaker after birth, and a gene mutation might be linked to eczema.

A chemical called 5-Bromo-2′-deoxyuridine caused rapid hair loss in mice by killing certain skin cells through a specific cell death pathway.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Thyroid disease can cause hair loss and treating thyroid problems might help with hair disorders.

The meeting highlighted the genetic basis of female pattern hair loss and various skin health insights.

Antiyeast treatments work better for seborrheic dermatitis than steroids, and other findings include increased skin bacteria under plastic wrap, a nasal cell defect in Staphylococcus aureus carriers, quick resolution of certain skin reactions, high rubber latex allergy in spina bifida patients, and glyceryl monopentadecanoate's effectiveness for male hair loss.

Treatments for hair loss include estrogen therapy and special shampoos.

Advancements in tissue engineering show promise for hair follicle regeneration to treat hair loss.

iPSCs could help develop treatments for hair loss.

Topical minoxidil helps treat hair loss in teens, but more research needed for safe options.

No treatment fully prevents hair loss from chemotherapy yet.

Possible new treatments for common hair loss include drugs, stem cells, and improved transplants.

Crash dieting can cause hair loss due to severe calorie restriction.

Nanotechnology improves minoxidil treatment for hair loss.

New hair follicles could be created to treat hair loss.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Light therapy might help treat hereditary hair loss by improving hair follicle growth in lab cultures.

The developed system could effectively treat hair loss and promote hair growth.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Platelet factor 4 slows down hair growth and could make hair loss treatments more effective if removed.

Dermal cells are key in controlling hair growth and could potentially be used in hair loss treatments, but more research is needed to improve hair regeneration methods.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

K16 can partially replace K14 but causes hair loss and skin issues.

N-acetylcysteine and ImuVert can prevent hair loss in rats caused by chemotherapy.

The new hydrogel treatment promotes faster hair growth and better skin health for hair loss.

A new method using a microfluidic device can prepare hair follicle germs efficiently for potential use in hair loss treatments.